Rheumatoid arthritis: reading & resources

The use of DMARDs, with methotrexate as the backbone of the treatment, has revolutionised rheumatoid arthritis management, but there is still room to maximise the benefit.

Read the full article

Patients with suspected rheumatoid arthritis should be referred promptly. Disease-modifying antirheumatic drugs are often used in combination and can have serious adverse effects. Their safe use requires ongoing monitoring.

Read the full article

Early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDS) and corticosteroids improves function and symptomatic and radiographic outcomes. Prescription and monitoring of DMARDs can be shared between specialists and non-specialists if pathways and communication are clear. Specialists are best placed to guide changes in DMARDS or corticosteroid treatment. 

Read the full article

There are several methotrexate 'myths' that may be believed by patients and health professionals, and propagated through word of mouth, information in print or on the internet. Providing patients with accurate information will help overcome obstacles to the use of an effective treatment for rheumatoid arthritis. 

Read the full article

Low-dose once-weekly methotrexate is the 'gold standard' disease-modifying antirheumatic drug (DMARD) to treat rheumatoid arthritis, other inflammatory arthritis and other autoimmune conditions.

Read the full article

Structured collaboration between patients, GPs, rheumatologists and other healthcare professionals can support an earlier start to treatment, better adherence and better outcomes. We provide an example of a shared care referral letter. Reproduced with permission.

This roadmap helps you navigate life with rheumatoid arthritis, from diagnosis to finding treatment that works for you.

Includes important information about how you should take methotrexate, possible side effects, tests and monitoring and other precautions when taking methotrexate. 

Read the full article

For people who have been recommended injections of methotrexate as a treatment for arthritis. Includes information about how patients and their family, friends or carers can safely inject methotrexate, the steps to follow and the equipment needed. 

Read the full article

Low-dose once-weekly methotrexate via a subcutaneous injection can be more effective and/or have fewer side effects than a once-a-week tablet. 

Watch this video

An interactive tool that supports discussions between health professionals and patients starting low-dose once-weekly methotrexate for rheumatoid arthritis. 

Download patient action plan

Keep track of your medicines and access important health info anytime and anywhere. The MedicineWise app gives you access to fact sheets and videos about managing medicines if you have rheumatoid arthritis and are taking low-dose methotrexate. You can receive notifications via the app to promote the use of folic acid and the value of flu vaccinations and annual skin checks. The app allows you to set dose reminders and record tests, measurements, allergies and reactions. 

Find out more about the app

Arthritis Australia's myRA website provides information and support to help people with rheumatoid arthritis live a better life with RA.

Visit the myRA website